Clinical trials: Moisture-associated Dermatitis
Moisture Associated Skin Damage, Incontinence Associated Dermatitis
Testing the Safety and Efficacy of a Novel Barrier Cream for the Treatment of Moisture Associated Skin Damage
Liquid stool and diarrhea are associated with an increased risk for moisture-associated skin damage (MASD), and clinical evidence suggests that exposure to liquid stool is associated with severe MASD and extensive erosion of…
- Conditions
- Moisture Associated Skin Damage, Incontinence Associated Dermatitis, Fecal Incontinence
- Trial name
- NCT06221046
- Testing
- Control (Standard treatment), Novel Barrier Cream
- Volunteers
- 60 people
- Sponsor
- Scotiaderm
Incontinence-associated Dermatitis, Moisture Associated Skin Damage
Seeing Red: Clinical Assessment Tools for Clinical Trial Decision Support
This research aims to assess the utility and validate the inter-rater reliability of the new nursing documentation tools for commonly encountered moisture-associated skin damage including (incontinence-associated dermatitis (IAD)…
- Conditions
- Incontinence-associated Dermatitis, Moisture Associated Skin Damage, Intertrigo
- Trial name
- NCT05760469
- Testing
- Screening
- Volunteers
- 20 people
- Sponsor
- Scotiaderm
Irritant Dermatitis, Stoma Site Dermatitis
Effectiveness of 3M Cavilon Advanced Skin Protectant in the Treatment of Moisture-associated Skin Damage in Hospitals
Objectives: The aim of this study is to evaluate the effectiveness of 3M™ Cavilon™ Advanced Skin Protectant in the treatment of partial-thickness wounds caused by moisture (MASD) compared to usual wound care treatment.
- Conditions
- Irritant Dermatitis, Stoma Site Dermatitis, Wound of Skin
- Trial name
- ISR-CASP-MASD (NCT06178289)
- Testing
- 3M Cavilon Advanced Skin Protectant, Standard hospital wound treatment protocol
- Where
- 3 sites in Belgium
- Volunteers
- 36 people
- Sponsor
- University Ghent
Moisture Associated Skin Damage, Fecal Incontinence
Testing a Novel Barrier Cream for Fecal Incontinence in an Ambulatory Population
Liquid stool and diarrhea are associated with an increased risk for moisture-associated skin damage (MASD), and clinical evidence suggests that exposure to liquid stool is associated with severe MASD and extensive erosion of…
- Conditions
- Moisture Associated Skin Damage, Fecal Incontinence, Incontinence Associated Dermatitis
- Trial name
- NCT06370637
- Testing
- Barrier Cream, Dermategrity Everyday Barrier Cream
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- Scotiaderm
Incontinence Associated Dermatitis
Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing
The purpose of the study is to evaluate the safety and efficacy of the investigational product (3M™ Cavilon™ Advanced High Endurance Skin Protectant) for the treatment of incontinence associated dermatitis.
- Trial name
- NCT02570139
- Testing
- Cavilon Advanced Skin Protectant, ConvaTec Sensi-Care Protective Barrier
- Where
- 10 sites in United States
- Volunteers
- 45 people
- Sponsor
- Solventum US LLC
Pressure Injury, Pressure Injury Prevention
Effect of a Standardized Moisture-Care Protocol Using Skin Barrier Spray on Prevention of Pressure Injuries in the Perineal-Sacral Area Among Incontinent Inpatients: A 3-month Pilot Study.
This pilot study aims to evaluate whether a standardized proactive moisture-care protocol using a silicone-based skin barrier spray can reduce early-stage pressure injuries (PIs) in the perineal-sacral area among incontinent…
- Trial name
- NCT07851519
- Testing
- Usual Care, Intervention Group
- Where
- Hong Kong
- Volunteers
- 70 people
- Sponsor
- United Christian Hospital
Moisture-associated Dermatitis, Fungal Infection in Perineal Area
Clinical Case Series Evaluating Skin Wellness System
The purpose of this evaluation is to observe the performance of two (2) different skin care treatment protocols on the skin: #1 Kendall™ Body Wash \& Shampoo in combination with the Moisture Barrier Cream; or #2 Kendall™ 2-in-1…
- Trial name
- NCT01724229
- Where
- 2 sites in United States
- Volunteers
- 20 people
- Sponsor
- GM Associates
Incontinence-associated Dermatitis, Decubitus Ulcer
Safety and Efficacy of RashEndZ Wound Aeration Technology
The aim of this study is to determine the safety and efficacy of RashEndZ therapeutic liner technology and Dynamic Oxygen Skin Therapy in improving symptoms and expediting healing of IAD and DU in adult patients.
- Trial name
- NCT07899060
- Testing
- Dynamic Oxygen Skin Therapy (DOST), Standard Wound Care
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- RashEndZ Inc.